BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+3.37%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$957M
AUM Growth
+$1.08M
(+0.11%)
Cap. Flow
-$8.63M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
140
New
9
Increased
34
Reduced
55
Closed
6
Top Buys
| 1 |
DexCom
DXCM
|
$12.7M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.1M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$9.58M |
| 4 |
Incyte
INCY
|
$8.07M |
| 5 |
CELG
Celgene Corp
CELG
|
$7.5M |
Top Sells
| 1 |
Amgen
AMGN
|
$20.3M |
| 2 |
Gilead Sciences
GILD
|
$15.9M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$10.9M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$8.6M |
| 5 |
AbbVie
ABBV
|
$8.05M |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Financials | 0.41% |
| 3 | Industrials | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
76
DELISTED
Sage Therapeutics
SAGE
| $2.08M | 0.22% |
+12,650
| New | +$2.08M |
|
77
Globus Medical
GMED
$8.14B
| $2.01M | 0.21% |
48,850
-6,150
| -11% | -$253K |
|
78
Healthcare Services Group
HCSG
$1.14B
| $2M | 0.21% |
38,000
| – | – |
|
|
JUNO
79
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.92M | 0.2% |
41,900
-1,100
| -3% | -$50.3K |
|
80
Ultragenyx Pharmaceutical
RARE
$3.01B
| $1.9M | 0.2% |
40,900
-1,100
| -3% | -$51K |
|
|
NUVA
81
DELISTED
NuVasive, Inc.
NUVA
| $1.89M | 0.2% |
32,312
-13,892
| -30% | -$813K |
|
|
82
AbbVie
ABBV
$376B
| $1.89M | 0.2% |
19,500
-83,277
| -81% | -$8.05M |
|
83
iRhythm Technologies
IRTC
$5.85B
| $1.87M | 0.2% |
33,400
| – | – |
|
84
HCA Healthcare
HCA
$96.3B
| $1.87M | 0.2% |
21,300
| – | – |
|
85
Quanterix
QTRX
$201M
| $1.8M | 0.19% |
+83,800
| New | +$1.8M |
|
|
EGRX
86
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.76M | 0.18% |
33,000
-48,550
| -60% | -$2.59M |
|
87
Qiagen
QGEN
$10.2B
| $1.75M | 0.18% |
53,387
-4,716
| -8% | -$155K |
|
88
AngioDynamics
ANGO
$436M
| $1.69M | 0.18% |
101,700
| – | – |
|
89
Teladoc Health
TDOC
$1.35B
| $1.64M | 0.17% |
47,000
| – | – |
|
|
TRHC
90
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.63M | 0.17% |
58,000
+2,593
| +5% | +$72.7K |
|
91
Penumbra
PEN
$10.9B
| $1.58M | 0.17% |
16,800
| – | – |
|
92
Halozyme
HALO
$8.59B
| $1.56M | 0.16% |
77,000
-10,600
| -12% | -$215K |
|
93
Merck
MRK
$210B
| $1.55M | 0.16% |
28,820
| – | – |
|
94
Exelixis
EXEL
$10.1B
| $1.54M | 0.16% |
50,600
-1,400
| -3% | -$42.6K |
|
95
Masimo
MASI
$7.77B
| $1.44M | 0.15% |
17,000
| – | – |
|
96
iShares Biotechnology ETF
IBB
$5.68B
| $1.44M | 0.15% |
13,500
-13,500
| -50% | -$1.44M |
|
|
ITCI
97
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.34M | 0.14% |
92,500
+52,500
| +131% | +$760K |
|
98
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $1.32M | 0.14% |
+150,000
| New | +$1.32M |
|
|
CYTO
99
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $1.28M | 0.13% |
27
| – | – |
|
|
IPXL
100
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.25M | 0.13% |
75,000
-12,000
| -14% | -$200K |
|